Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Melina Rapoport is active.

Publication


Featured researches published by Melina Rapoport.


Journal of Clinical Microbiology | 2009

Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae.

Fernando Pasteran; Tania Mendez; Leonor Guerriero; Melina Rapoport; Alejandra Corso

ABSTRACT The detection of class A serine-carbapenemases among species of Enterobacteriaceae remains a challenging issue. Methods of identification for routine use in clinical microbiology laboratories have not been standardized to date. We developed a novel screening methodology suitable for countries with high basal levels of carbapenem resistance due to non-carbapenemase-mediated mechanisms and standardized several simple confirmatory methods that allow the recognition of bacteria producing class A carbapenemases, including KPC, Sme, IMI, NMC-A, and GES, by using boronic acid (BA) derivatives. A total of 28 genetically unrelated Enterobacteriaceae strains producing several class A carbapenemases were tested. Thirty-eight genetically unrelated negative controls were included. The isolates were tested against imipenem (IPM), meropenem (MEM), and ertapenem (ETP) by MIC and disk diffusion assays in order to select appropriate tools to screen for suspected carbapenemase production. It was possible to differentiate class A carbapenemase-producing bacteria from non-carbapenemase-producing bacteria by using solely the routine IPM susceptibility tests. The modified Hodge test was evaluated and found to be highly sensitive, although false-positive results were documented. Novel BA-based methods (a double-disk synergy test and combined-disk and MIC tests) using IPM, MEM, and ETP, in combination with 3-aminophenylboronic acid as an inhibitor, were designed as confirmatory tools. On the basis of the performance of these methods, a sensitive flow chart for suspicion and confirmation of class A carbapenemase production in species of Enterobacteriaceae was designed. By using this methodology, isolates producing KPC, GES, Sme, IMI, and NMC-A carbapenemases were successfully distinguished from those producing other classes of β-lactamases (extended-spectrum β-lactamases, AmpCs, and metallo-β-lactamases, etc). These methods will rapidly provide useful information needed for targeting antimicrobial therapy and appropriate infection control.


Journal of Clinical Microbiology | 2010

Controlling False-Positive Results Obtained with the Hodge and Masuda Assays for Detection of Class A Carbapenemase in Species of Enterobacteriaceae by Incorporating Boronic Acid

Fernando Pasteran; Tania Mendez; Melina Rapoport; Leonor Guerriero; Alejandra Corso

ABSTRACT The modified Hodge method (MHT) has been recommended by the CLSI for confirmation of suspected class A carbapenemase production in species of Enterobacteriaceae. This test and the Masuda method (MAS) have advantages over traditional phenotypic methods in that they directly analyze carbapenemase activity. In order to identify the potential interferences of these tests, we designed a panel composed of diverse bacterial genera with distinct carbapenem susceptibility patterns (42 carbapenemase producers and 48 nonproducers). About 25% of results among carbapenemase nonproducers, mainly strains harboring CTX-M and AmpC hyperproducers, were observed to be false positive. Subsequently, we developed an optimized approach for more-accurate detection of suspicious isolates of carbapenemase by addition of boronic acid (BA) derivatives (reversible inhibitor of class A carbapenemases and AmpC cephalosporinases) and oxacillin (inhibitor of AmpCs enzymes). The use of the modified BA- and oxacillin-based MHT and MAS resulted in high sensitivity (>90%) and specificity (100%) for class A carbapenemase detection. By use of these methodologies, isolates producing KPCs and GES, Sme, IMI, and NMC-A carbapenemases were successfully distinguished from those producing other classes of ß-lactamases (extended-spectrum β-lactamases [ESBLs], AmpC β-lactamases, metallo-β-lactamases [MBLs], etc.). These methods will provide the fast and useful information needed for targeting of antimicrobial therapy and appropriate infection control.


Emerging Infectious Diseases | 2008

Klebsiella pneumoniae Carbapenemase-2, Buenos Aires, Argentina.

Fernando Pasteran; Luis Otaegui; Leonor Guerriero; Gabriel Radice; Ricardo Maggiora; Melina Rapoport; Diego Faccone; Ana di Martino; Marcelo Galas

Fil: Pasteran, Fernando. ANLIS Dr.C.G.Malbran. Instituto Nacional de Enfermedades Infecciosas; Argentina.


Antimicrobial Agents and Chemotherapy | 2016

First Description of mcr-1-Mediated Colistin Resistance in Human Infections Caused by Escherichia coli in Latin America.

Melina Rapoport; Diego Faccone; Fernando Pasteran; Paola Ceriana; Ezequiel Albornoz; Alejandro Petroni; Alejandra Corso

Yi-Yun Liu and colleagues recently reported the emergence of plasmid-mediated colistin resistance in China, raising a great concern around the world (1-5).…


Journal of Clinical Microbiology | 2011

Sensitive and Specific Modified Hodge Test for KPC and Metallo-Beta- Lactamase Detection in Pseudomonas aeruginosa by Use of a Novel Indicator Strain, Klebsiella pneumoniae ATCC 700603

Fernando Pasteran; Omar Veliz; Melina Rapoport; Leonor Guerriero; Alejandra Corso

ABSTRACT We evaluated the ability of the modified Hodge test to discriminate between KPC- and metallo-beta-lactamase (MBL)-producing Pseudomonas aeruginosa isolates and carbapenemase nonproducers. With Escherichia coli ATCC 25922 as the indicator strain, the MHT resulted in low sensitivity, specificity, and repeatability. Replacing the indicator strain with Klebsiella pneumoniae ATCC 700603 led to an improved performance (100%, 97%, 0%, and 100% sensitivity, specificity, indeterminate results and repeatability, respectively).


Antimicrobial Agents and Chemotherapy | 2004

CARB-9, a Carbenicillinase Encoded in the VCR Region of Vibrio cholerae Non-O1, Non-O139 Belongs to a Family of Cassette-Encoded β-Lactamases

Alejandro Petroni; Roberto Melano; Héctor A. Saka; Alicia Garutti; Laura Mange; Fernando Pasteran; Melina Rapoport; Mariana Miranda; Diego Faccone; Alicia Rossi; Paul S. Hoffman; Marcelo Galas

ABSTRACT The gene blaCARB-9 was located in the Vibrio cholerae super-integron, but in a different location relative to blaCARB-7. CARB-9 (pI 5.2) conferred β-lactam MICs four to eight times lower than those conferred by CARB-7, differing at Amblers positions V97I, L124F, and T228K. Comparison of the genetic environments of all reported blaCARB genes indicated that the CARB enzymes constitute a family of cassette-encoded β-lactamases.


Antimicrobial Agents and Chemotherapy | 2002

New Carbenicillin-Hydrolyzing β-Lactamase (CARB-7) from Vibrio cholerae Non-O1, Non-O139 Strains Encoded by the VCR Region of the V. cholerae Genome

Roberto G. Melano; Alejandro Petroni; Alicia Garutti; Héctor A. Saka; Laura Mange; Fernando Pasteran; Melina Rapoport; Alicia Rossi; Marcelo Galas

ABSTRACT In a previous study, an analysis of 77 ampicillin-nonsusceptible (resistant plus intermediate categories) strains of Vibrio cholerae non-O1, non-O139, isolated from aquatic environment and diarrheal stool, showed that all of them produced a β-lactamase with a pI of 5.4. Hybridization or amplification by PCR with a probe for blaTEM or primers for blaCARB gene families was negative. In this work, an environmental ampicillin-resistant strain from this sample, ME11762, isolated from a waterway in the west region of Argentina, was studied. The nucleotide sequence of the structural gene of the β-lactamase was determined by bidirectional sequencing of a Sau3AI fragment belonging to this isolate. The gene encodes a new 288-amino-acid protein, designated CARB-7, that shares 88.5% homology with the CARB-6 enzyme; an overall 83.2% homology with PSE-4, PSE-1, CARB-3, and the Proteus mirabilis N29 enzymes; and 79% homology with CARB-4 enzyme. The gene for this β-lactamase could not be transferred to Escherichia coli by conjugation. The nucleotide sequence of the flanking regions of the blaCARB-7 gene showed the occurrence of three 123-bp V. cholerae repeated sequences, all of which were found outside the predicted open reading frame. The upstream fragment of the blaCARB-7 gene shared 93% identity with a locus situated inside V. choleraes chromosome 2. These results strongly suggest the chromosomal location of the blaCARB-7 gene, making this the first communication of a β-lactamase gene located on the VCR island of the V. cholerae genome.


Antimicrobial Agents and Chemotherapy | 2007

Identification of the Novel Narrow-Spectrum β-Lactamase SCO-1 in Acinetobacter spp. from Argentina

Laurent Poirel; Stéphane Corvec; Melina Rapoport; Pauline D. Mugnier; Alejandro Petroni; Fernando Pasteran; Diego Faccone; Marcelo Galas; Henri Drugeon; Vincent Cattoir; Patrice Nordmann

ABSTRACT By studying the β-lactamase content of several Acinetobacter spp. isolates from Argentina, producing the expanded-spectrum β-lactamases (ESBL) VEB-1a or PER-2, a novel Ambler class A β-lactamase gene was identified. It encoded the narrow-spectrum β-lactamase SCO-1, whose activity was inhibited by clavulanic acid. SCO-1 hydrolyzes penicillins at a high level and cephalosporins and carbapenems at a very low level. β-Lactamase SCO-1 was identified from unrelated VEB-1a-positive or PER-2-positive Acinetobacter spp. isolates recovered from three hospitals. The blaSCO-1 gene was apparently located on a plasmid of ca. 150 kb from all cases but was not associated with any ESBL-encoding gene. The G+C content of the blaSCO gene was 52%, a value that does not correspond to that of the A. baumannii genome (39%). β-Lactamase SCO-1 shares 47% amino acid identity with CARB-5 and ca. 40% with the enzymes TEM, SHV, and CTX-M. A gene encoding a putative resolvase was identified downstream of the blaSCO-1 gene, but its precise way of acquisition remains to be determined.


Journal of Clinical Microbiology | 2015

Evaluation of the Blue-Carba Test for Rapid Detection of Carbapenemases in Gram-Negative Bacilli

Fernando Pasteran; Omar Veliz; Paola Ceriana; Celeste Lucero; Melina Rapoport; Ezequiel Albornoz; Sonia Gomez; Alejandra Corso

The Blue-Carba test (BCT) is a biochemical test for rapid (<2 h) detection of carbapenemase production in Gram-negative bacilli directly from bacterial culture ([1][1]). It is based on the in vitro hydrolysis of imipenem by bacterial colonies (direct inoculation without prior lysis), which is


Journal of Antimicrobial Chemotherapy | 2012

Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina

Fernando Pasteran; Diego Faccone; Sonia Gomez; Sabrina De Bunder; Federico Spinelli; Melina Rapoport; Alejandro Petroni; Marcelo Galas; Alejandra Corso

Servicio Antimicrobianos, Departamento Bacteriologia, Instituto Nacional de Enfermedades Infecciosas (INEI), ANLIS ‘Dr Carlos G. Malbran’, Ciudad Autonoma de Buenos Aires, Argentina; Bacteriologia, Hospital Zonal de Bariloche ‘Ramon Carillo’, Rio Negro, Argentina; Infectologia, Hospital Privado Regional del Sur, Rio Negro, Argentina; Infectologia, Sanatorio del Sol, Bariloche, Rio Negro, Argentina

Collaboration


Dive into the Melina Rapoport's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sonia Gomez

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. De Belder

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

D. Faccone

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge